期刊文献+

脆性髋部骨折手术与非手术治疗的临床疗效分析 被引量:1

Clinical efficacy of surgery or non-surgery in treatment of fragility hip fracture
原文传递
导出
摘要 目的通过随访脆性髋部骨折不同治疗方法的临床疗效,为髋部脆性骨折的治疗提供指导。方法收集2010—2012年入住我院且获得随访的286例50岁以上脆性髋部骨折患者的住院及随访资料,统计分析手术与非手术组患者恢复优良率、死亡率。结果 2010—2012年我院共收住脆性髋部骨折患者560例,获得随访286例,其中采用手术治疗的250例,非手术治疗的36例,手术组病人功能恢复优良率达85.60%,非手术组病人功能恢复优良率仅为22.22%,2者差异有统计学意义(χ2=81.815,P<0.01)。手术组病人随访期死亡率10.00%,非手术组随访期病人随访期死亡率高达69.44%,2者差异有统计学意义(χ2=77.081,P<0.01)。结论脆性髋部骨折致残率及死亡率高,条件允许的情况下采用手术治疗可以显著降低患者的病死率,促进髋部功能的恢复,提高患者的生活质量。 Objective To evaluate the clinical efficacy of surgery or non-surgery in the treatment of fragility hip fracture so as to provide the guidance for the hip fragile fracture treatment. Methods A total of 286 over 50 years old patients with hip fragile fracture patients were followed up from 2010 to 2012. All the data were analyzed statistically and compared between the surgery group and non-surgery group. Results Among the 286 patients, 250 patients were treated with surgery, and 36 were treated with non-surgieal therapy. The good and excellent rates were 85.60% in the surgery group and 22.22% in the non-surgery group, respectively, and the difference between the two groups was statistically significant (X2 = 81. 815, P〈0.01). The mortality of the surgery group was 10.00%, and the mortality of the non-surgery group was 69.44 %, and the difference between the two groups was statistically significant (X2 = 77. 081, P 〈 0.01 ). Conclusions The disability rate and mortality of hip fragile fracture are high. The surgery could reduce the mortality in permit condition, promote the hip function recovery, and improve the quality of life of the patients.
出处 《中国校医》 2014年第5期362-364,共3页 Chinese Journal of School Doctor
关键词 髋骨折/外科手术 髋骨折/治疗 治疗结果 Hip Fracture/surgery Hip Fracture/therapy Treatment Outcome
  • 相关文献

参考文献13

  • 1Moran CG, Wenn RT, Sikand M, et al. Eariy mortality after hip fracture:is delay before surgery important? [J ]. J Bone Joint Surg Am, 2005,87(3) :483 - 489.
  • 2李毅中,陈献南,李炎川.高龄老人股骨颈骨质疏松性骨折的治疗[J].中国骨质疏松杂志,2005,11(3):342-343. 被引量:21
  • 3林金矿,李毅中,俞海明,姚学东,庄华烽.利伐沙班预防老年人髋部骨折术后下肢深静脉血栓形成的研究[J].中华创伤骨科杂志,2011,13(9):885-887. 被引量:25
  • 4Xia WB, He SL, Xu L, et al. Rapidly increasing rates of hip fracture in Beijing, China[J ]. J Bone Miner Res, 2012,27( 1 ):125 - 129.
  • 5Lewis JR, Hassan SK, Wenn RT, et al. Mortality and serum urea and electrolytes on admission for hip fracture patients[J ]. Injury, 2006,37(8) :698 - 704.
  • 6吴鸿亮,吴培斌,熊含颖,张志平,李洪波.68例高龄患者髋部骨折的临床治疗分析[J].南昌大学学报(医学版),2011,51(3):72-73. 被引量:5
  • 7Simunovic N, Devereaux PJ, Sprague S, et al. Effect of early surgery after hip" fracture on mortality and complications:systematic review and meta-analysis[J ]. CMAJ,2010,182(15) : 1609 - 1616.
  • 8Rogmark C,Johnell O. Primary arthroplasty is better than interna- l fixation of displaced femoral neck fractures: a meta-analysis of 14 randomized studies with 2 289 patients[ J ]. Acta Orthop, 2006,77 (3) :359 - 367.
  • 9Gjertsen JE, Vinje T, Engesaeter LB, et al. Internal .screw fixation compared with bipolar hemiarthroplasty for treatment of displaced femoral neck fractures in elderly patients [ J ]. J Bone Joint Surg Am,2010,92(3) :619 - 628.
  • 10Palm H, Lys+n C, Krasbeninnikoff M, et al. Intramedullary nailing appears to be superior in pertrochanterie hip fractures with a detached greater trochanter:311 consecutive patients followed for 1 year[J]. Acta Orthop,2011,82(2) : 166 - 170.

二级参考文献31

  • 1周青,沈云.股骨转子间骨折两种髓内固定方法的比较[J].中华创伤骨科杂志,2005,7(8):730-733. 被引量:54
  • 2安智全,王烨明,曾炳芳.经皮穿针导入股骨近端髓内钉内固定治疗股骨转子间骨折的前瞻性研究[J].中华创伤骨科杂志,2006,8(9):816-819. 被引量:44
  • 3Marsland D, Mears SC, Kates SL. Venous thromboembolic prophylaxis for hip fractures. Osteoporos Int, 2010, 21(Suppl 4):S593-S604.
  • 4Kudrnová Z, Kvasnicka J, Kudrna K, et al. Favorable coagulation profile with fondaparinux after hip surgery in elderly patients. Int J Hematol, 2009, 90: 476-482.
  • 5Borris LC. New compounds in the management of venous thromboembolism afterorthopedic surgery: focus on rivaroxaban. Vasc Health Risk Manag, 2008, 4: 855-862.
  • 6Cha SI, Lee SY, Kim CH, et al. Venous thromboembolism in Korean patients undergoing major orthopedic surgery: a prospective observational study using computed tomographic (CT) pulmonary angiography and indirect CT venography. J Korean Med Sci, 2010, 25: 28-34.
  • 7Turpie AG, Lassen MR, Davidson BL, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet, 2009, 373: 1673-1680.
  • 8Eriksson BI, Lassen MR, PENTasaccharide in HIp-FRActure Surgery Plus Investigators. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med, 2003, 163: 1337-1342.
  • 9Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines(8th Edition). Chest, 2008,133:381 S-453S.
  • 10EINSTEIN Investigator, Bauersachs R, Berkowitz SD, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med,2010, 363: 2499-2510.

共引文献326

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部